On June 29, 2020 the Gairdner Foundation convened leaders from across Canada to discuss the national research response to COVID-19.
Topics of discussion ranged from Canadian vaccine efforts, population wide research and impact and national coordination and collaboration.
The panel was moderated by Janet Rossant, President and Scientific Director of the Gairdner Foundation.
Speakers included:
Mona Nemer – Chief Science Advisor of Canada
Michael Strong – President, CIHR-IRSC
Lakshmi Krishnan – Director General, Human Health Therapeutics, National Research Council of Canada
Volker Gerdts – Director & CEO, VIDO-Intervac
Gary Kobinger – Canada Research Chair in Immunotherapy and Innovative Vaccine Platforms, Université Laval
Rob Annan – President & CEO, Genome Canada
Catherine Hankins – Co-Chair, COVID-19 Immunity Task Force, McGill University
Carrie Bourrassa, Scientific Director, CIHR Institute of Indigenous Peoples’ Health
Guy Rouleau – Director, Montreal Neurological Institute and Hospital, McGill University & 2020 Canada Gairdner Wightman Award Laureate
Vivek Goel – Vice-President, Research and Innovation, and Strategic Initiatives, University of Toronto
